Although 10 weeks is not a long time in terms of research, there are SURF students who are able to produce enough work to achieve authorship on manuscripts.  Here is a sampling of SURF-related publications.  The students are highlighted in bold.

Bostian, AC, Maddukuri, L, Reed, MR, Savenka, T, Hartman, JH, Davis, LE, Pouncey, DL, Miller, GP, Eoff, RL (2015) “Kynurenine signaling increases DNA polymerase kappa expression and promotes genomic instability in glioblastoma cells” Chem Res Tox, in press

Hartman, JH, Martin, HC, Caro, AA, Pearce AR, Miller, GP (2015) “Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates,” Toxicol 338:47-58.

Hartman, JH, Miller, GP, Boysen, G (2014) “Inhibitory Potency of 4-Carbon Alkanes and Alkenes toward CYP2E1 Activity,” Toxicol, 318:51-8.

Pugh, CP, Pouncey, DL, Hartman, JH, Nshimiyimana, R, Desrochers, LP, Goodwin, TE, Boysen G, Miller, GP (2014) “Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites,” Arch Biochem Biophys 564:244-53

Kovak MR, Saraswati S., Goddard, SD, Diekman AB (2013) Proteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomes. Andrology 1: 682-691. DOI: 10.1111/j.2047-2927.2013.00099.x.

Pawlowska, M, Chu, R, Fedejko-Kap, B, Augustin, E, Mazerska, Z, Radominska-Pandya, A, Chambers, TC. (2013) “Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.” Drug Metab Dispos 41:414-21.

Pianalto,KM, Hartman, JH, Boysen, G, Miller, GP (2013) “Differences in Butadiene Adduct Formation between Rats and Mice Not Due to Selective Inhibition of CYP2E1 by Butadiene Metabolites,” Toxicol Lett 223, 221-227. PMC3831829

Hartman, JH, Knott, AK, Miller GP (2013) “CYP2E1 Hydroxylation of Aniline Involves Negative Cooperativity,” Biochem Pharmacol 87, 523-33. PMID24345333

Byrum SD, Larson SK, Avaritt NL, Moreland LE, Mackintosh SG, Cheung W, Tackett AJ (2013) Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma. J Proteomics Bioinform, 6 (3), 43-50.

Hartman, JH, Bradley, AM, Laddusaw, RM, Perry Jr, MD, Miller, GP (2013) “Structure of Pyrazole Derivatives Impact their Affinity, Stoichiometry, and Cooperative Interactions for CYP2E1 Complexes.” Arch Biochem Biophys 537, 12-20. PMC3781954

Byrum, S, Smart, SK, Larson, SK, and Tackett, AJ (2012) Analysis of Stable and Transient Protein-Protein Interactions. Methods in Mol Biol, 833, 143-52.

Hartman, JH, Boysen, G, Miller, GP, (2012) “CYP2E1 Metabolism of Styrene Involves Allostery,” Drug Metab Dispos, in press.

Ketkar A, Zafar MK, Banerjee S, Marquez VE, Egli M, Eoff RL (2012) A nucleotide-analogue-induced gain of function corrects the error-prone nature of human DNA polymerase iota. J. Am. Chem. Soc. 2012 Jun 27;134(25): 10698-705. Epub 2012 Jun 14

Jones DR, Kim SY, Guderyon M, Yun CH, Moran JH, Miller GP (2010) Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. Chem Res Toxicol. 2010 May 17;23(5):939-45.  [Abstract]

Elbein, AD, Pastuszak, I, Tackett, AJ, Wilson, T, Pan, YT (2010) The last step in the conversion of trehalose to glycogen:A mycobacterial enzyme that transfers maltose from maltose-1-phosphate to glycogen. J Biol Chem, in press.  [Abstract]

Ounpraseuth S, Rafferty TM, McDonald-Phillips RE, Gammill WM, Siegel ES, Wheeler KL, Nilsson EA, Cooney CA (2009) A Method to Quantify Mouse Coat-Color Proportions. PLoS ONE in press  [Abstract]

Collom, SL, Laddusaw, RM, Kuzmic, P, Burch, AM, Perry, Jr, MD, Miller, GP (2008) CYP2E1 Substrate Inhibition: Mechanistic interpretation through an effector site for monocyclic compounds. J Biol Chem, in press.  [Abstract]

Jamakhandi, AP, Kuzmic, P, Sanders, DA, Miller, GP (2007) Global Analysis of Protein-Protein Interactions Reveals Multiple CYP2E1-Reductase Complexes. Biochemistry 46, 10192-201.  [Abstract]

Collom, SL, Jamakhandi, AP, Tackett, AJ, Radominska-Pandya, A, and Miller, GP (2006) CYP2E1 active site residues in Substrate Recognition Sequence 5 identified by photoaffinity labeling and homology modeling. Archives Biochem Biophys, 459, 59-69.[Abstract]

Upreti, M, Lyle, CS, Skaug, B, Du, L, and Chambers, TC.  (2006) Vinblastine-induced apoptosis is mediated by discrete alterations in the subcellular distribution, oligomeric structure, and activation status of specific Bcl-2 family members.  J. Biol. Chem. 281, 15941-15950. [Abstract]

Kurmasheva RT, Peterson CA, Parham DM, Chen B, McDonald RE, Cooney CA. (2005) Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas. Pediatr Blood Cancer. 44:328-37. [Abstract]

Ebert RH II, Shammas MA, Sohal BH, Sohal RS, Egilmez NK, Ruggles S, Shmookler Reis RJ. (1996) Defining genes that govern longevity in Caenorhabditis elegans. Devel. Genet. 18:131-143. [Abstract]

Ebert RH II, Cherkasova VA, Dennis RA, Wu JH, Ruggles S, Eudy Perrin T, and Shmookler Reis RJ. (1993) Longevity-determining genes in Caenorhabditis elegans: Chromosomal mapping of multiple noninteractive loci. Genetics 135: 1003-1010. [Abstract]